Company Filing History:
Years Active: 2025
Title: The Innovations of Mitchell Kluesner
Introduction
Mitchell Kluesner is an accomplished inventor based in Minneapolis, MN. He has made significant contributions to the field of gene editing and immunotherapy. His work focuses on advancing methods for targeted gene disruption and modification in mammalian cells.
Latest Patents
Kluesner holds a patent for "Lymphohematopoietic engineering using CAS9 base editors." This patent outlines methods and systems for targeted gene disruption, including knock-out and missense mutation techniques. It also details the use of guide RNAs designed to target splice acceptor-splice donor sites. The patent further describes genetically engineered cells with targeted disruptions in immunotherapy-related genes, which include a CAR/TCR for therapeutic applications. He has 1 patent to his name.
Career Highlights
Mitchell Kluesner is affiliated with the University of Minnesota, where he conducts research and develops innovative solutions in the field of gene editing. His work has the potential to impact therapeutic applications significantly.
Collaborations
Some of his notable coworkers include Branden Moriarity and Beau R Webber, who collaborate with him on various research projects.
Conclusion
Mitchell Kluesner's contributions to gene editing and immunotherapy represent a significant advancement in the field. His innovative approaches and patented technologies are paving the way for future developments in medical therapies.